Award
National Institute of Neurological Disorders and Stroke 7R01NS146509-02
Mechanism of alpha5 integrin contribution to Amyotrophic Lateral Sclerosis pathology
Recipient
Cedars-Sinai Medical Center
Award Amount
$674,731.00
Ceiling
$674,731.00
Awarded
July 24, 2026
Identifier
7R01NS146509-02
Award for research on the role of alpha5 integrin in ALS pathology by Cedars-Sinai Medical Center, funded by NINDS with an amount of approximately $674,731.
Description
The project focuses on investigating the role of α5 integrin in ALS pathology, including genetic and cellular studies. Funded by the National Institute of Neurological Disorders and Stroke (NINDS). Project duration from April 1, 2026, to March 31, 2031.